The global cell therapy monitoring kits market was valued at USD 1.4 billion in 2025. It is expected to reach USD 1.5 billion in 2026 and is projected to grow to USD 2.5 billion by 2033, registering a 7.6% CAGR from 2026 to 2033. North America accounted for the largest regional share at 40.2% in 2025, while Asia Pacific is expected to record the fastest growth, with a 12.9% CAGR during 2026–2033.

The market is expanding as cell and gene therapies move through clinical development and commercialization. Growing clinical trial activity, tighter regulatory requirements, and advances in assay automation are increasing the need for standardized monitoring kits that can assess critical cell characteristics and support quality control.

Market at a Glance

What Is Driving Demand for Cell Therapy Monitoring Kits?

Expansion of Cell and Gene Therapy Clinical Trials

The growing global pipeline of cell and gene therapies (CGT) is creating sustained demand for monitoring and testing solutions. CAR-T therapies, stem cell treatments, and gene-edited therapies are progressing through clinical development and commercial manufacturing, increasing the number of quality-control checkpoints where monitoring kits are required.

Cell therapies must be evaluated during critical stages including cell isolation, modification, expansion, and infusion. Testing parameters such as cell viability, purity, identity, and potency helps manufacturers and healthcare providers assess product quality and maintain process consistency.

Because living-cell products can be highly sensitive to manufacturing and handling variations, batch-specific and frequent monitoring is particularly important. This supports broader adoption of specialized cell therapy monitoring kits.

Download a free sample report or claim your copy of this full market intelligence report

Increasing Regulatory and Quality-Control Requirements

Regulatory frameworks established by organizations such as the U.S. FDA and European Medicines Agency (EMA) place stringent requirements on the safety, identity, purity, potency, and quality of cell therapy products.

Compliance with Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) requires manufacturers to implement rigorous testing and documentation procedures throughout development and production. Monitoring kits support these requirements by enabling standardized assessments, traceability, and batch-to-batch quality evaluation.

As the number of approved cell therapies and clinical programs increases, regulatory scrutiny is also expected to intensify. This creates a favorable environment for advanced monitoring technologies capable of delivering reliable and reproducible results.

Technology and Product Trends

Technology development is reshaping how cell therapy quality is assessed. Ready-to-use assay kits simplify laboratory workflows, while automated flow cytometry platforms can reduce manual intervention, minimize testing variability, and improve reproducibility between laboratories.

The shift toward standardized and automation-compatible solutions is particularly relevant as cell therapy manufacturing expands across multiple facilities and geographies. Consistent testing methodologies can help organizations maintain quality standards while improving operational efficiency.

Market Segmentation Highlights

• By product: Immune cell differentiation and expansion kits represented the largest segment, accounting for 40.0% of the market in 2025.
• By application: Oncology was the leading application segment, with a 36.1% share in 2025.
• By therapy type: CAR T-cell therapies accounted for the largest share at 34.2% in 2025.
• By end use: Hospitals and clinics represented the leading end-use segment, holding 41.5% of the market in 2025.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Regional Performance

North America remained the dominant regional market in 2025, supported by an established biotechnology ecosystem, significant cell therapy research activity, and strong regulatory and quality-control infrastructure. The region accounted for 40.2% of global revenue.

Asia Pacific is positioned as the fastest-growing regional market, projected to expand at a 12.9% CAGR from 2026 to 2033. Increasing investment in biotechnology, expanding clinical research capabilities, and growing adoption of advanced cell therapies are contributing to regional market opportunities.

At the country level, the U.S. held the largest market share in 2025, reflecting its mature cell and gene therapy development ecosystem and substantial clinical research activity.

Competitive Landscape

Major companies profiled in the cell therapy monitoring kits market include:

• STEMCELL Technologies Inc.
• Lonza Group
• Thermo Fisher Scientific Inc.
• Merck KGaA (Sigma-Aldrich)
• BD Biosciences
• Miltenyi Biotec

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• S. Healthcare Facility Mapping & Intelligence Portal – Claims analytics (MS-DRG, service lines, ICD-10 outpatient, APC reimbursement, CPT-level) plus hospital-level financials (balance sheet, income statement, uncompensated care, financial health dashboards), covering 25,000+ healthcare facilities — including 7,000+ hospitals, independent pharmacies, freestanding EDs, concierge physicians, and ASCs.
• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.